全文获取类型
收费全文 | 66984篇 |
免费 | 4942篇 |
国内免费 | 361篇 |
专业分类
耳鼻咽喉 | 755篇 |
儿科学 | 1652篇 |
妇产科学 | 1660篇 |
基础医学 | 8379篇 |
口腔科学 | 1699篇 |
临床医学 | 6666篇 |
内科学 | 14982篇 |
皮肤病学 | 888篇 |
神经病学 | 5249篇 |
特种医学 | 2028篇 |
外国民族医学 | 2篇 |
外科学 | 10394篇 |
综合类 | 1168篇 |
现状与发展 | 1篇 |
一般理论 | 105篇 |
预防医学 | 5421篇 |
眼科学 | 1946篇 |
药学 | 4705篇 |
中国医学 | 168篇 |
肿瘤学 | 4419篇 |
出版年
2023年 | 320篇 |
2022年 | 536篇 |
2021年 | 1290篇 |
2020年 | 796篇 |
2019年 | 1095篇 |
2018年 | 1351篇 |
2017年 | 937篇 |
2016年 | 1094篇 |
2015年 | 1263篇 |
2014年 | 1898篇 |
2013年 | 3017篇 |
2012年 | 4042篇 |
2011年 | 4377篇 |
2010年 | 2511篇 |
2009年 | 2315篇 |
2008年 | 4184篇 |
2007年 | 4404篇 |
2006年 | 4188篇 |
2005年 | 4294篇 |
2004年 | 4022篇 |
2003年 | 3608篇 |
2002年 | 3536篇 |
2001年 | 833篇 |
2000年 | 742篇 |
1999年 | 810篇 |
1998年 | 783篇 |
1997年 | 638篇 |
1996年 | 513篇 |
1995年 | 518篇 |
1994年 | 485篇 |
1993年 | 459篇 |
1992年 | 563篇 |
1991年 | 544篇 |
1990年 | 456篇 |
1989年 | 493篇 |
1988年 | 424篇 |
1987年 | 406篇 |
1986年 | 382篇 |
1985年 | 441篇 |
1984年 | 456篇 |
1983年 | 405篇 |
1982年 | 534篇 |
1981年 | 453篇 |
1980年 | 497篇 |
1979年 | 307篇 |
1978年 | 328篇 |
1977年 | 329篇 |
1976年 | 268篇 |
1975年 | 292篇 |
1974年 | 249篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
Rajendrababu Sharmila Puthuran George Varghese Alia Laxmi Ananya Uduman Mohammed Sithiq Wijesinghe Hiruni Kaushalya 《International ophthalmology》2022,42(8):2609-2618
International Ophthalmology - To investigate the efficacy and safety of non-valved Aurolab aqueous drainage implant (AADI) surgery combined with phacoemulsification in eyes with refractory glaucoma... 相似文献
3.
In the 6th Basic Plan for Long-Term Electricity Supply and Demand (6th BPE) for Korea, for the first time, the environmental costs of air pollution caused by oxides of sulfur (SOx), oxides of nitrogen (NOx), and particulate matters (PM) from power plants were estimated and included. However, several deficiencies in evaluating the environmental costs were found. In this study, (1) the validity of the environmental costs used in the 6th BPE was assessed, (2) a systematic approach was suggested and used to improve the environmental costs estimation, and (3) the sensitivity of the cost of generating electricity to the environmental costs by fuel type with the proposed approach was discussed. We found that the applied environmental costs used in the 6th BPE did not fully include the demographic characteristics of Korea. By applying more realistic parameter values, it was found that the newly estimated environmental cost was about 23 times higher than the cost estimated in the original 6th BPE for coal-fired power plants and about 1.5 times higher for liquefied natural gas (LNG)-fired power plants, suggesting that LNG-fired power plants are more economical if using more realistic environmental costs. Thus, it is critical to check the validity of parameter values when calculating environmental costs. 相似文献
4.
5.
6.
7.
8.
9.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献10.